Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018

Background: Ocular and orbit melanoma is a rare subtype of melanoma for which outcomes have not been adequately reported. We have analyzed the incidence-based mortality trends of ocular and orbit melanoma over 15 years in USA. Most ocular melanomas originate from the uvea and, to a lesser extent, fr...

Full description

Saved in:
Bibliographic Details
Published in:International journal of general medicine 2021-01, Vol.14, p.4171-4176
Main Authors: Valasapalli, Srijan, Guddati, Achuta Kumar
Format: Article
Language:English
Subjects:
Alaska
Analysis
Epidemiology
Immunotherapy
incidence
India
Kinases
Medical imaging
Medical research
Medicine, Experimental
Melanoma
Mortality
Native Americans
ocular melanoma
Original Research
Patient outcomes
trend
Trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c553t-a5881ce1c17eec0e7f57c67bb5c63d41020a182725676f7f262a50367c1dfb8e3
cites cdi_FETCH-LOGICAL-c553t-a5881ce1c17eec0e7f57c67bb5c63d41020a182725676f7f262a50367c1dfb8e3
container_end_page 4176
container_issue
container_start_page 4171
container_title International journal of general medicine
container_volume 14
creator Valasapalli, Srijan
Guddati, Achuta Kumar
description Background: Ocular and orbit melanoma is a rare subtype of melanoma for which outcomes have not been adequately reported. We have analyzed the incidence-based mortality trends of ocular and orbit melanoma over 15 years in USA. Most ocular melanomas originate from the uvea and, to a lesser extent, from the conjunctiva. Primary orbital melanoma is exceedingly rare. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried to find the incidence-based mortality for all patients diagnosed with ocular and orbit melanoma for the years 2000 to 2018. Results were grouped by gender and race (Caucasian/White, African American/Black, American Indian/Alaskan Native, and Asian/Pacific Islanders). A paired t-test was used to determine the statistically significant difference between various subgroups (p < 0.05). Results: Incidence-based mortality has been the highest in Caucasian/White patients from 2000 to 2018, followed by African American/Black and Asian/Pacific Islander patients. American Indian/Alaskan native patients appear to have the least mortality. There was a statistically significant difference (p
doi_str_mv 10.2147/IJGM.S299144
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_64b4710387e044da9c3299050f7a73e3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A676189990</galeid><doaj_id>oai_doaj_org_article_64b4710387e044da9c3299050f7a73e3</doaj_id><sourcerecordid>A676189990</sourcerecordid><originalsourceid>FETCH-LOGICAL-c553t-a5881ce1c17eec0e7f57c67bb5c63d41020a182725676f7f262a50367c1dfb8e3</originalsourceid><addsrcrecordid>eNptUl1rFDEUHUSxtfrmDwgI4oOzJpPP8aGwFq0rXSu0xceQydzZzTKb1GRG6b830120K5KHG27OOeEcTlG8JHhWESbfLb6cL2dXVV0Txh4Vx4RIVUos2eMH96PiWUobjIUQhD4tjiijiisqjwv4agYXfPndtYCuI_g2IefRwtu88BbKDyZBi5YhDqZ3wx0KHfqWKeCHhH65YY0u7dibiJbQGx-2ZmLfXM3fowpjjIaQJ1HPiyed6RO82M-T4ubTx-uzz-XF5fnibH5RWs7pUBquFLFALJEAFoPsuLRCNg23graM4AoboipZcSFFJ7tKVIZjKqQlbdcooCfFYqfbBrPRt9FtTbzTwTh9vwhxpU0cnO1BC9YwSTBVEjBjraktzRlijjtpJAWatU53Wrdjs4XWZsfR9Aeihy_erfUq_NSKcoYrkgXe7AVi-DFCGvTWJQt9zgnCmHR2QZjitaoz9NU_0E0Yo89R3aOkVFUt_qJWJhtwvgv5XzuJ6nkOhKg6G8io2X9Q-bSwdTZ46FzeHxBePyCswfTDOoV-nHqRDoFvd0AbQ0oRuj9hEKynLuqpi3rfRfobFJPKLg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561778296</pqid></control><display><type>article</type><title>Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018</title><source>Taylor &amp; Francis Open Access</source><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Valasapalli, Srijan ; Guddati, Achuta Kumar</creator><creatorcontrib>Valasapalli, Srijan ; Guddati, Achuta Kumar</creatorcontrib><description>Background: Ocular and orbit melanoma is a rare subtype of melanoma for which outcomes have not been adequately reported. We have analyzed the incidence-based mortality trends of ocular and orbit melanoma over 15 years in USA. Most ocular melanomas originate from the uvea and, to a lesser extent, from the conjunctiva. Primary orbital melanoma is exceedingly rare. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried to find the incidence-based mortality for all patients diagnosed with ocular and orbit melanoma for the years 2000 to 2018. Results were grouped by gender and race (Caucasian/White, African American/Black, American Indian/Alaskan Native, and Asian/Pacific Islanders). A paired t-test was used to determine the statistically significant difference between various subgroups (p &lt; 0.05). Results: Incidence-based mortality has been the highest in Caucasian/White patients from 2000 to 2018, followed by African American/Black and Asian/Pacific Islander patients. American Indian/Alaskan native patients appear to have the least mortality. There was a statistically significant difference (p&lt;0.05) in mortality between Caucasian/White patients from 2000 to 2018, and African American/Black and Asian/Pacific Islander patients. The sample size for African American/Black and American Indian/Alaskan native patients was too low to discern a meaningful trend in mortality. Overall, it appears that Caucasian males and females have a far higher and worsening incidence-based mortality compared to other races. Conclusion: Ocular melanoma and orbit melanoma are rare entities that are predominantly seen in Caucasian/White patients. This study shows that incidence-based mortality has been worsening for these patients in the past two decades. These entities have a poor prognosis and have not been studied extensively in immunotherapy trials. There is a need for new clinical trials to help improve mortality rates. Keywords: ocular melanoma, mortality, trend, incidence</description><identifier>ISSN: 1178-7074</identifier><identifier>EISSN: 1178-7074</identifier><identifier>DOI: 10.2147/IJGM.S299144</identifier><identifier>PMID: 34385837</identifier><language>eng</language><publisher>Macclesfield: Dove Medical Press Limited</publisher><subject>Alaska ; Analysis ; Epidemiology ; Immunotherapy ; incidence ; India ; Kinases ; Medical imaging ; Medical research ; Medicine, Experimental ; Melanoma ; Mortality ; Native Americans ; ocular melanoma ; Original Research ; Patient outcomes ; trend ; Trends</subject><ispartof>International journal of general medicine, 2021-01, Vol.14, p.4171-4176</ispartof><rights>COPYRIGHT 2021 Dove Medical Press Limited</rights><rights>2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Valasapalli and Guddati. 2021 Valasapalli and Guddati.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c553t-a5881ce1c17eec0e7f57c67bb5c63d41020a182725676f7f262a50367c1dfb8e3</citedby><cites>FETCH-LOGICAL-c553t-a5881ce1c17eec0e7f57c67bb5c63d41020a182725676f7f262a50367c1dfb8e3</cites><orcidid>0000-0003-4070-9498 ; 0000-0002-9390-0424</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2561778296/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2561778296?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,44571,53772,53774,74875</link.rule.ids></links><search><creatorcontrib>Valasapalli, Srijan</creatorcontrib><creatorcontrib>Guddati, Achuta Kumar</creatorcontrib><title>Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018</title><title>International journal of general medicine</title><description>Background: Ocular and orbit melanoma is a rare subtype of melanoma for which outcomes have not been adequately reported. We have analyzed the incidence-based mortality trends of ocular and orbit melanoma over 15 years in USA. Most ocular melanomas originate from the uvea and, to a lesser extent, from the conjunctiva. Primary orbital melanoma is exceedingly rare. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried to find the incidence-based mortality for all patients diagnosed with ocular and orbit melanoma for the years 2000 to 2018. Results were grouped by gender and race (Caucasian/White, African American/Black, American Indian/Alaskan Native, and Asian/Pacific Islanders). A paired t-test was used to determine the statistically significant difference between various subgroups (p &lt; 0.05). Results: Incidence-based mortality has been the highest in Caucasian/White patients from 2000 to 2018, followed by African American/Black and Asian/Pacific Islander patients. American Indian/Alaskan native patients appear to have the least mortality. There was a statistically significant difference (p&lt;0.05) in mortality between Caucasian/White patients from 2000 to 2018, and African American/Black and Asian/Pacific Islander patients. The sample size for African American/Black and American Indian/Alaskan native patients was too low to discern a meaningful trend in mortality. Overall, it appears that Caucasian males and females have a far higher and worsening incidence-based mortality compared to other races. Conclusion: Ocular melanoma and orbit melanoma are rare entities that are predominantly seen in Caucasian/White patients. This study shows that incidence-based mortality has been worsening for these patients in the past two decades. These entities have a poor prognosis and have not been studied extensively in immunotherapy trials. There is a need for new clinical trials to help improve mortality rates. Keywords: ocular melanoma, mortality, trend, incidence</description><subject>Alaska</subject><subject>Analysis</subject><subject>Epidemiology</subject><subject>Immunotherapy</subject><subject>incidence</subject><subject>India</subject><subject>Kinases</subject><subject>Medical imaging</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Melanoma</subject><subject>Mortality</subject><subject>Native Americans</subject><subject>ocular melanoma</subject><subject>Original Research</subject><subject>Patient outcomes</subject><subject>trend</subject><subject>Trends</subject><issn>1178-7074</issn><issn>1178-7074</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUl1rFDEUHUSxtfrmDwgI4oOzJpPP8aGwFq0rXSu0xceQydzZzTKb1GRG6b830120K5KHG27OOeEcTlG8JHhWESbfLb6cL2dXVV0Txh4Vx4RIVUos2eMH96PiWUobjIUQhD4tjiijiisqjwv4agYXfPndtYCuI_g2IefRwtu88BbKDyZBi5YhDqZ3wx0KHfqWKeCHhH65YY0u7dibiJbQGx-2ZmLfXM3fowpjjIaQJ1HPiyed6RO82M-T4ubTx-uzz-XF5fnibH5RWs7pUBquFLFALJEAFoPsuLRCNg23graM4AoboipZcSFFJ7tKVIZjKqQlbdcooCfFYqfbBrPRt9FtTbzTwTh9vwhxpU0cnO1BC9YwSTBVEjBjraktzRlijjtpJAWatU53Wrdjs4XWZsfR9Aeihy_erfUq_NSKcoYrkgXe7AVi-DFCGvTWJQt9zgnCmHR2QZjitaoz9NU_0E0Yo89R3aOkVFUt_qJWJhtwvgv5XzuJ6nkOhKg6G8io2X9Q-bSwdTZ46FzeHxBePyCswfTDOoV-nHqRDoFvd0AbQ0oRuj9hEKynLuqpi3rfRfobFJPKLg</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Valasapalli, Srijan</creator><creator>Guddati, Achuta Kumar</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4070-9498</orcidid><orcidid>https://orcid.org/0000-0002-9390-0424</orcidid></search><sort><creationdate>20210101</creationdate><title>Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018</title><author>Valasapalli, Srijan ; Guddati, Achuta Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c553t-a5881ce1c17eec0e7f57c67bb5c63d41020a182725676f7f262a50367c1dfb8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alaska</topic><topic>Analysis</topic><topic>Epidemiology</topic><topic>Immunotherapy</topic><topic>incidence</topic><topic>India</topic><topic>Kinases</topic><topic>Medical imaging</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Melanoma</topic><topic>Mortality</topic><topic>Native Americans</topic><topic>ocular melanoma</topic><topic>Original Research</topic><topic>Patient outcomes</topic><topic>trend</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Valasapalli, Srijan</creatorcontrib><creatorcontrib>Guddati, Achuta Kumar</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of general medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Valasapalli, Srijan</au><au>Guddati, Achuta Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018</atitle><jtitle>International journal of general medicine</jtitle><date>2021-01-01</date><risdate>2021</risdate><volume>14</volume><spage>4171</spage><epage>4176</epage><pages>4171-4176</pages><issn>1178-7074</issn><eissn>1178-7074</eissn><abstract>Background: Ocular and orbit melanoma is a rare subtype of melanoma for which outcomes have not been adequately reported. We have analyzed the incidence-based mortality trends of ocular and orbit melanoma over 15 years in USA. Most ocular melanomas originate from the uvea and, to a lesser extent, from the conjunctiva. Primary orbital melanoma is exceedingly rare. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried to find the incidence-based mortality for all patients diagnosed with ocular and orbit melanoma for the years 2000 to 2018. Results were grouped by gender and race (Caucasian/White, African American/Black, American Indian/Alaskan Native, and Asian/Pacific Islanders). A paired t-test was used to determine the statistically significant difference between various subgroups (p &lt; 0.05). Results: Incidence-based mortality has been the highest in Caucasian/White patients from 2000 to 2018, followed by African American/Black and Asian/Pacific Islander patients. American Indian/Alaskan native patients appear to have the least mortality. There was a statistically significant difference (p&lt;0.05) in mortality between Caucasian/White patients from 2000 to 2018, and African American/Black and Asian/Pacific Islander patients. The sample size for African American/Black and American Indian/Alaskan native patients was too low to discern a meaningful trend in mortality. Overall, it appears that Caucasian males and females have a far higher and worsening incidence-based mortality compared to other races. Conclusion: Ocular melanoma and orbit melanoma are rare entities that are predominantly seen in Caucasian/White patients. This study shows that incidence-based mortality has been worsening for these patients in the past two decades. These entities have a poor prognosis and have not been studied extensively in immunotherapy trials. There is a need for new clinical trials to help improve mortality rates. Keywords: ocular melanoma, mortality, trend, incidence</abstract><cop>Macclesfield</cop><pub>Dove Medical Press Limited</pub><pmid>34385837</pmid><doi>10.2147/IJGM.S299144</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4070-9498</orcidid><orcidid>https://orcid.org/0000-0002-9390-0424</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-7074
ispartof International journal of general medicine, 2021-01, Vol.14, p.4171-4176
issn 1178-7074
1178-7074
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_64b4710387e044da9c3299050f7a73e3
source Taylor & Francis Open Access; PMC (PubMed Central); Publicly Available Content (ProQuest)
subjects Alaska
Analysis
Epidemiology
Immunotherapy
incidence
India
Kinases
Medical imaging
Medical research
Medicine, Experimental
Melanoma
Mortality
Native Americans
ocular melanoma
Original Research
Patient outcomes
trend
Trends
title Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nation-Wide%20Trends%20in%20Incidence-Based%20Mortality%20of%20Patients%20with%20Ocular%20Melanoma%20in%20USA:%202000%20to%202018&rft.jtitle=International%20journal%20of%20general%20medicine&rft.au=Valasapalli,%20Srijan&rft.date=2021-01-01&rft.volume=14&rft.spage=4171&rft.epage=4176&rft.pages=4171-4176&rft.issn=1178-7074&rft.eissn=1178-7074&rft_id=info:doi/10.2147/IJGM.S299144&rft_dat=%3Cgale_doaj_%3EA676189990%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c553t-a5881ce1c17eec0e7f57c67bb5c63d41020a182725676f7f262a50367c1dfb8e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2561778296&rft_id=info:pmid/34385837&rft_galeid=A676189990&rfr_iscdi=true